A1-ADRENERGIC RECEPTORS PREVENT PATHOLOGIC VENTRICULAR REMODELING FOLLOWING MI

Medicine & Life Sciences

1. Ventricular Remodeling 100%
2. Muscle Cells 77%
3. Heart Failure 61%
4. Adrenergic Receptors 56%
5. Hypoxia 39%
6. Organized Financing 39%
7. Coronary Occlusion 39%
8. Catecholamines 31%
9. Transgenic Mice 30%
10. Coronary Vessels 27%
11. Myocardial Infarction 24%
12. Mortality 16%
13. Cardiac Myocytes 15%
14. Norepinephrine 14%
15. Research Personnel 11%
16. Clinical Trials 10%
17. Heart 10%
18. Costs and Cost Analysis 10%